In this article, we will discuss Rucaparib (Description). So, let’s get started.
Rucaparib is a targeted cancer therapy belonging to the class of drugs known as PARP inhibitors. Here’s a brief description:
Mechanism of Action:
Rucaparib works by inhibiting the activity of poly (ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair. By blocking PARP, the drug prevents cancer cells, particularly those with deficiencies in other DNA repair mechanisms, from repairing damaged DNA. This leads to the accumulation of DNA damage, ultimately causing cell death.